{
    "@graph": [
        {
            "@id": "https://www.tib.eu/de/suchen/id/TIBKAT%3A73734556X",
            "@type": "bibo:Thesis",
            "P1053": "Online-Ressource (PDF-Datei: 3,9 MB)",
            "contributor": [
                "Oppermann, Martin",
                "Kube, Dieter",
                "Wulf, Gerald",
                "Simons, Mikael"
            ],
            "creator": "Hupfeld, Timo",
            "identifier": [
                "(ppn)73734556X",
                "(firstid)GBV:73734556X"
            ],
            "subject": [
                "(classificationName=ddc-dbn)570",
                "(classificationName=linseach:mapping)bio",
                "(classificationName=linseach:mapping)meda",
                "(classificationName=ddc-dbn)610"
            ],
            "title": "Zur Resistenzentwicklung von Zellen der chronischen myeloischen Leuk\u00e4mie gegen\u00fcber Tyrosinkinase-Inhibitoren : Regulation und Funktion des ABC-Transporters A3",
            "abstract": [
                "Bei der Mehrzahl der Patienten mit chronischer myeloischer Leuk\u00e4mie (CML) induziert die Inhibition der BCR-ABL-Tyrosinkinaseaktivit\u00e4t durch die spezifischen BCR-ABL-Inhibitoren (TKI) Imatinib, Nilotinib und Dasatinib eine vollst\u00e4ndige Remission der Erkrankung. Allerdings kommt es nach dem Absetzen der Therapie oder dem Erwerb einer Resistenz-vermittelnden Mutation des bcr/abl-Gens zu einem R\u00fcckfall, ausgehend von einer kleinen Zellfraktion, die w\u00e4hrend der Prim\u00e4rtherapie persistieren konnte. In Vorarbeiten zu leuk\u00e4mischen Vorl\u00e4uferzellen mit dem Ph\u00e4notyp der \"side population\" (SP) wurde ber...",
                "Inhibition of the BCR-ABL tyrosine kinase activity by the specific tyrosine kinase inhibitors (TKI) imatinib, nilotinib and dasatinib leads to complete remission of the disease in most patients with chronic myeloid leukemia (CML). Cessation of CML treatment or the occurrence of resistance mediating bcr/abl gene mutations leads to relapse of the disease, initiated by a small fraction of cells that persisted during CML therapy. Those cells are CD34 positive leukemic progenitor cells with the phenotype of the \"side population\" and show high expression of the intracellular ABC transporter A3 (A..."
            ],
            "alternative": "regulation and function of the ABC transporter A3",
            "dcterms:contributor": "Technische Informationsbibliothek (TIB)",
            "isPartOf": "(collectioncode)GBV-ODiss",
            "issued": "2012",
            "language": "http://id.loc.gov/vocabulary/iso639-1/de",
            "license": "open access",
            "medium": "rda:termList/RDACarrierType/1018",
            "relation": "http://creativecommons.org/licenses/by-nc-nd/3.0/"
        }
    ],
    "@id": "urn:x-arq:DefaultGraphNode",
    "@context": {
        "identifier": "http://purl.org/dc/elements/1.1/identifier",
        "subject": "http://purl.org/dc/elements/1.1/subject",
        "contributor": "http://purl.org/dc/elements/1.1/contributor",
        "medium": {
            "@id": "http://purl.org/dc/terms/medium",
            "@type": "@id"
        },
        "relation": "http://purl.org/dc/terms/relation",
        "abstract": "http://purl.org/dc/terms/abstract",
        "license": "http://purl.org/dc/terms/license",
        "alternative": "http://purl.org/dc/terms/alternative",
        "P1053": "http://iflastandards.info/ns/isbd/elements/P1053",
        "title": "http://purl.org/dc/elements/1.1/title",
        "issued": "http://purl.org/dc/terms/issued",
        "language": {
            "@id": "http://purl.org/dc/terms/language",
            "@type": "@id"
        },
        "creator": "http://purl.org/dc/elements/1.1/creator",
        "isPartOf": "http://purl.org/dc/terms/isPartOf",
        "umbel": "http://umbel.org/umbel#",
        "rdau": "http://www.rdaregistry.info/Elements/u/#",
        "owl": "http://www.w3.org/2002/07/owl#",
        "dcterms": "http://purl.org/dc/terms/",
        "bibo": "http://purl.org/ontology/bibo/",
        "rdam": "http://www.rdaregistry.info/Elements/m/#",
        "gnd": "http://d-nb.info/gnd/",
        "isbd": "http://iflastandards.info/ns/isbd/elements/",
        "rda": "http://rdvocab.info/",
        "doi": "https://doi.org/"
    }
}